European Leukemia Trial Registry
Trial: AML 2003 SAL

More Details
Title standardtherapy vs. intensified therapy
Scientific Title Randomized Comparison Between Standard-Therapy and Intensified Therapy for Adult Acute Myeloid Leukemia Patients <= 60 Years. A Prospective, Randomized, Multi-Center Therapy-Optimizing-Study
Short Title AML 2003 SAL
Trialgroup DSIL
Type of Trial multicentric, randomized
Disease Acute myeloid leukemia(AML) AML all subtypes without FAB M3
Age <= 60 years
Status No longer recruiting
Start of Recruitment 01.12.2003
Leader Ehninger, Prof. Dr. med., Gerhard
Contactperson

Study Physician
Schaich, Prof. Dr. med., Markus
Tel: +49 (0)7195 591-39240
Fax: +49 (0)7195 591-939240
Email: markus.schaich@rems-murr-kliniken.de

Biometrics
Koch, Prof. Dr. rer. nat., Rainer
Tel: +49 (0)351 3177 216
Fax: +49 (0)351 3177 225
Email: koch@imib.med.tu-dresden.de
Homepage: www.imib.med.tu-dresden.de/imib/index.html

Study Centre
Kamratowsky, Philipp
Tel: +49 (0)351 458 4969
Fax: +49 (0)351 458 4367
Email: philipp.kamratowsky@uniklinikum-dresden.de

Study Centre
Oelsner, Robert
Tel: +49 (0)351 458 4969
Fax: +49 (0)351 458 4367
Email: robert.oelsner@uniklinikum-dresden.de

Centre of Trial Universitätsklinikum Carl Gustav Carus, Dresden
Shortprotocol Shortprotocol
Diagnostics

Central diagnostics
Hämatologisches Labor, Universitätsklinikum Dresden

Remark Amendment I from 01. August 2004; Amendment II from 01. December 2007; Amendment III from 01. December 2008; www.sal-aml.org
created 19.06.2006 Anja Hellenbrecht
changed 16.10.2014 Hanna Ebert
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org